Canadian scientists are racing to develop a way to diagnose Chronic Traumatic Encephalopathy (CTE) in people still alive, a disease that has only been confirmed post‑mortem. The effort, spearheaded by Neil Vasdev at the Brain Health Imaging Centre, centres on advanced imaging of veterans and athletes, including former soldier Brendan Hynes, who suffers from panic attacks, suicidal thoughts and anger that ended his military career.

Vasdev’s Vision: First‑In‑World In‑Life CTE Imaging

According to the report,Vasdev’s team hopes to become the first worldwide to successfully image and diagnose CTE while a patient is still alive. The goal is not only to confirm a diagnosis but also to halt or reverse the disease’s progression. The study, described as “massive” and “years‑long,” will scan thousands of participants for biological markers that could signal CTE before symptoms fully manifest.

Hynes’ Personal Stakes : Symptoms That Ended a Military Career

Brendan Hynes, a former Canadian soldier with 27 years of bomb‑blast exposure, is one of the study’s key participants. He lies in an MRI machine at Toronto’s Centre for Addiction and Mental Health (CAMH) as researchers collect data. Hynes’ symptoms—panic attacks, suicidal thoughts, uncontrollable anger and depression—are typical of CTE, yet a confirmed diagnosis remains impossible while he is alive . The report notes that the Canadian army listed CTE on his release paperwork, but medical confirmation is still out of reach.

CTE’s Global Legacy: From Football to Hockey to the Battlefield

The disease’s profile rose worldwide after Dr. Bennet Omalu identified it in football player Mike Webster, leading to hundreds of posthumous diagnoses in athletes.. The report cites the recent suicide of former NHL player Claude Lemieux , whose brain will be studied, as underscoring the urgency of early detection. CTE often develops years after repeated head trauma, whether from contact sports or explosive blasts, and can lead to substance abuse, financial ruin, violence, and early death.

Key Unknowns: What Markers Will Be Found?

While the study promises a breakthrough,the source does not yet reveal which imaging techniques or biomarkers will prove definitive. It also leaves unanswered whether the findings will translate into effective treatments. The report acknowledges that, even if imaging succeeds, stopping or reversing CTE remains a future challenge.